Bis-imidazolinylindoles are active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Mycobacterium tuberculosis

Journal of Antibiotics

Volumn 66, Issue 1, 2013, Pages 47-49

  Panchal, Rekha G ^a   Lane, Douglas ^b   Boshoff, Helena I ^c   Butler, Michelle M ^d   Moir, Donald T ^d   Bowlin, Terry L ^d   Bavari, Sina ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d MICROBIOTIX INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; MBX 1066; MBX 1090; MBX 1113; MBX 1128; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GROWTH; BACTERIAL MUTATION; CONCENTRATION RESPONSE; CYTOTOXICITY; DNA BINDING; DNA SYNTHESIS INHIBITION; DRUG POTENCY; ESCHERICHIA COLI; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE; IMIDAZOLIDINES; INDOLES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84873821215     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2012.93     Document Type: Article

References (8)

1. Grundmann, H., Aires-de-Sousa, M., Boyce, J. & Tiemersma, E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368, 874-885 (2006
2. Anti-tuberculosis drug resistance in the world. Fourth global report. Vol. 394 The WHO/ IUATLD Global Project on Antituberculosis Drug Resistance Surveillance (World Health Organization, Geneva, WHO/HTM/TB 10-12, 2008
3. Alexander, P. E. & De, P. The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the esulting public health threat from extensively drug-resistant TB, globally and in Canada. Can. J. Infect. Dis. Med. Microbiol. 18, 289-291 (2007
4. Panchal, R. G. et al. Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains. Antimicrob. Agents Chemother. 53, 4283-4291 (2009
5. Opperman, T. J. et al. Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR. Bioorg. Med. Chem. 18, 2123-2130 (2010
6. Butler, M. M. et al. Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates. Antimicrob. Agents Chemother. 54, 3974-3977 (2010
7. Jeon, C. Y. et al. Extensively drug-resistant tuberculosis in South Korea: Risk factors and treatment outcomes among patients at a tertiary referral hospital. Clin. Infect. Dis. 46, 42-49 (2008
8. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A7; Approved standard- Seventh Edition. (Clinical and Laboratory Standards Institute, Wayne, PA, 2006